Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trialBrent A. Neuschwander‐Tetri, Edward Doo, Rohit Loomba et al.|The Lancet|2014Cited by 2.2k
Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver DiseaseMichael Charlton, Atif Zaman, Eugene R. Schiff et al.|Gastroenterology|2015Cited by 799
Evidence-Based Incorporation of Serum Sodium Concentration Into MELDScott W. Biggins, Göran Klintmalm, W. Ray Kim et al.|Gastroenterology|2006Cited by 777
Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus InfectionKimberly Workowski, Raymond T. Chung, Marc G. Ghany et al.|Clinical Infectious Diseases|2018Cited by 726
Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of TransplantationMichael R. Lucey, Lewis Teperman, Norah A. Terrault et al.|Liver Transplantation|2012Cited by 544